AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Lyell Immunopharma, Inc. Director's Dealing 2023

Jul 20, 2023

Director's Dealing

Opens in your device viewer

Issuer: Lyell Immunopharma, Inc. (LYEL)
CIK: 0001806952
Period of Report: 2023-07-01

Reporting Person: Lang Matthew (Chief Business Officer)